A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Clinical trial NCT02639260 · COMPLETED
Trial details
- NCT number
- NCT02639260
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-07
- Primary completion
- 2018-06-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.